By Ben Butkus

Having recently been awarded a key patent covering its core microfluidic sample-processing cartridge technology, PositiveID subsidiary MicroFluidic Systems is ratcheting up its R&D and partnering activities in an attempt to commercialize a rapid, multiplex, real-time PCR-based molecular diagnostic device incorporating the technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.